A Mini-Review on the Effect of Docosahexaenoic Acid (DHA) on Cerulein-Induced and Hypertriglyceridemic Acute Pancreatitis.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hypertriglyceridemia 2 endocrinologydiseases
hyperlipidemia 1 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
hyperlipidemia 19786 pathogenesis of hyperlipidemic acute pancreatitis. Therefore, high DHA doses should be avoided for hyperlipidemia patients, for preventing the development of acute pancreatitis.7. Other Omega-3 Fatty Acids and PancreatitisCell
hypertriglyceridemia 17927 (Figure 2). At pharmacological doses (3–4 g/day), omega-3 PUFAs acids significantly reduce TG levels in hypertriglyceridemia patients [[87]]. Compared to EPA, DHA demonstrated a higher efficacy for the reduction of TG (DHA, −8
hypertriglyceridemia 18425 addition of omega-3 PUFAs to statin prevents the development of acute pancreatitis in patients with hypertriglyceridemia .6. Effect of High Concentration of DHA on Hyperlipidemic Acute PancreatitisA high concentration (1 mM)

You must be authorized to submit a review.